A TCR-mimetic bispecific binds the NY-ESO-1/HLA-A*02 peptide-MHC on tumor cells and CD3 on T cells, creating an immunological synapse that activates T cells to kill the target cell via perforin/granzyme-mediated apoptosis (and Fas/FasL pathways).